Have a personal or library account? Click to login
Case report. Role of the Methylene Tetrahydrofolate Reductase (MTHFR) Gene Mutation in Acute Myocardial Infarction Cover

Case report. Role of the Methylene Tetrahydrofolate Reductase (MTHFR) Gene Mutation in Acute Myocardial Infarction

By: Beáta Jakó and  János Sinkó  
Open Access
|May 2017

References

  1. 1. Warren T, Barry V, Hooker S, Xuemei S, ChurchT, Blair S. Sedentary Behaviors Increase Risk of Cardiovascular Disease Mortality in Men. Med Sci Sports Exerc. 2010;42:879-885. doi:10.1249/MSS.0b013e3181c3aa7e.
  2. 2. Maas A, Appelman Y. Gender differences in coronary heart disease. Neth Heart J. 2010;18:598-602.10.1007/s12471-010-0841-y
  3. 3. Kumar A, Cannon C. Acute Coronary Syndromes: Diagnosis and Management, Part I. Mayo Clin Proc. 2009;84:917-938.10.4065/84.10.917
  4. 4. Previtali E, Bucciarelli P, Passamonti S, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Tranfus. 2011;9:120-138. doi: 10.2450/2010.0066-10.
  5. 5. Li XY, Cheng F, Zhang AJ, et al. Folate Deficiency and Gene Polymorphisms of MTHFR, MTR and MTRR Elevate the Hyperhomocysteinemia Risk. Clin Lab. 2017;63:523-533. doi: 10.7754/Clin.Lab.2016.160917.
  6. 6. Amrani-Midoun A, Kiando SR, Treard C, Jeunemaitre X, Bouatia-Naji N. The relationship between MTHFR C677T gene polymorphism and essential hypertension in a sample of an Algerian population of Oran city. Int J Cardiol. 2016;225:408-411. doi: 10.1016/j.ijcard.2016.10.027.
  7. 7. Ganguly P, Alam SA. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6. doi: 10.1186/1475-2891-14-6.
  8. 8. Nakai K, Naki K, HabanoW, Gurwitz D. Correlation between C677 T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD. Am J Cardiovasc Drugs. 2001;1:353-361.10.2165/00129784-200101050-00005
  9. 9. Zhang W, Wang M, Zhang P, et al. Role of methylenetetrahydrofolate reductase 677C→T polymorphism in the development of myocardial infarction: evidence from an original study and updated meta-analysis, Genes Genom. 2016;38:809-817. doi: 10.1007/s13258-016-0424-4.
  10. 10. Trabetti E. Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk. J Appl Genet. 2008;49:267-82. doi: 10.1007/BF03195624.
  11. 11. Ezzat H, Attia F, Mokhtar A, et al. Prevalence of thrombophilic gene polymorphisms (FVL G1691A and MTHFR C677T) in patients with myocardial infarction. Egyptian Journal of Medical Human Genetics, 2014;15:113-123. http://dx.doi.org/10.1016/j.ejmhg.2014.02.001.10.1016/j.ejmhg.2014.02.001
  12. 12. Liew S, Gupta E. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: Epidemiology, metabolism and the associated diseases, Eur J Med Genet. 2015;58:1-10. doi: 10.1016/j.ejmg.2014.10.004.
  13. 13. Ozgul M, Demircelik M, Gunes M, Eryoncu B. Recurrent Acute Coronary Syndromes With Normal Homocystein Level: A Mutation of MTHFR Gene. Gazi medical Journal. 2014;25:35-36. doi: http://dx.doi.org/10.12996/gmj.2014.09.
DOI: https://doi.org/10.1515/jce-2017-0006 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 41 - 43
Submitted on: Feb 8, 2017
Accepted on: Mar 17, 2017
Published on: May 17, 2017
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Beáta Jakó, János Sinkó, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.